1Z9I

A Structural Model for the Membrane-Bound Form of the Juxtamembrane Domain of the Epidermal Growth Factor Receptor

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D_15N-separated_NOESY	1.5 mM JX EGFR in 90 mM DPC 15N,13C, 90% H20, 10% D20	90% H20, 10% D20		5.0	1 atm	308
2	3D_13C-separated_NOESY	1.5 mM JX EGFR in 90 mM DPC 15N,13C, 90% H20, 10% D20	90% H20, 10% D20		5.0	1 atm	308
3	HNHA	1.5 mM JX EGFR in 90 mM DPC 15N,13C, 90% H20, 10% D20	90% H20, 10% D20		5.0	1 atm	308
4	TROSY	1.5 mM JX EGFR in 90 mM DPC 15N in dry acrylamide gel then compress in the NMR tube, 90% H20, 10% D20	90% H20, 10% D20		5.0	1 atm	308

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	500
2	Varian	INOVA	600
3	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing	the structures are based on a total of 1146 restraints: 1249 are NOE-derived distance constraints, 55 dihedral angle restraints, 27 RDC restraints, 21 distance restraints from paramagnetic probe studies.	VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	25

Additional NMR Experimental Information
Details	The structure was determined using triple-resonance NMR spectroscopy and also using restraints from paramagnetic probe studies.

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR
2	processing	NMRPipe
3	data analysis	NMRView	5.2.1
4	structure solution	CNS	1.1
5	refinement	CNS	1.1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.